Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) Principal investigator Ali Bazarbachi
Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) Principal investigator Vivek Patel
Outcome of patients with Intermediate risk Acute Myelogenous Leukemia in first remission and no detectable residual disease (MRD negative) transplanted with a haploidentical donor versus autografted Group Acute Leukemia Working Party (ALWP) Type of Stem Cell Treatment Principal investigator Norbert-Claude GORIN
Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT Group Acute Leukemia Working Party (ALWP) Principal investigator Annalisa Ruggeri
The role of measurable residual disease (MRD) at the time of allogeneic stem cell transplantation in patients with AML in CR transplanted from unrelated donors with Post transplant cyclophosphamide Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
PTCY MMUD vs Haplo in active disease for AML Group Acute Leukemia Working Party (ALWP) Principal investigator Frédéric Baron
Trends in non sibling donor in HSCT CR2 Diseases Group Acute Leukemia Working Party (ALWP) Principal investigator Mohamad Mohty
Trends in donor characteristics for unrelated Stem Cell Transplantation in patients with acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
Haploidentical versus matched sibling donors hematopoietic stem cell transplantation for adult patients with relapsed/refractory acute lymphoblastic leukemia Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
Trends in allogeneic stem cell transplantation (HSCT) over two decades in patients with secondary acute myelogenous leukemia (sAML) being transplanted from sibling (MSD) or unrelated donors (UD). A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
COLLECTION OF NEXT-GENERATION SEQUENCING (NGS) DATA AND USE OF NOVEL DRUGS IN ACUTE LEUKEMIA PATIENTS Group Acute Leukemia Working Party (ALWP) Type of Stem Cell Treatment Principal investigator Prof M. Mohty
Outcome after allogeneic SCT for MLL-PTD AML Group Acute Leukemia Working Party (ALWP) Principal investigator Marta Pratcorona